Načítá se...
Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy
Intraperitoneal (IP) chemotherapy has revived hopes during the past few years for the management of peritoneal disseminations of digestive and gynecological cancers. Nevertheless, a poor drug penetration is one key drawback of IP chemotherapy since peritoneal neoplasms are notoriously resistant to d...
Uloženo v:
| Vydáno v: | Drug Deliv |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011950/ https://ncbi.nlm.nih.gov/pubmed/29589479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1455764 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|